melatonin has been researched along with devazepide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Bonouali-Pellissier, S | 1 |
| Jaworek, J; Konturek, SJ; Leja-Szpak, A; Nawrot, K; Pawlik, WW; Thor, P | 1 |
| Acuña-Castroviejo, D; Escames, G; García-Navarro, A; González-Puga, C; León, J; López-Cantarero, M; Ros, E | 1 |
4 other study(ies) available for melatonin and devazepide
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Melatonin is involved in cholecystokinin-induced changes of ileal motility in rats.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Electromyography; Gastrointestinal Motility; Ileum; Indoleacetic Acids; Male; Melatonin; Muscle, Smooth; Pineal Gland; Rats; Rats, Wistar; Receptors, Cholecystokinin; Thiazoles | 1994 |
Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro.
Topics: Amylases; Animals; Benzodiazepines; Capsaicin; Cells, Cultured; Cholecystokinin; Devazepide; Dose-Response Relationship, Drug; Melatonin; Pancreas; Pancreatic Juice; Rats; Rats, Wistar; Receptors, Melatonin; Tryptamines; Tryptophan; Vagotomy; Vagus Nerve | 2004 |
Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Devazepide; Dose-Response Relationship, Drug; Drug Synergism; Gastrins; Growth Inhibitors; HT29 Cells; Humans; Melatonin; Proglumide; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Sincalide | 2005 |